Search Results
Search for other papers by Nele Friedrich in
Google Scholar
PubMed
Endocrinologists 2007 ), which highlights the need for early screening markers to monitor the development of T2DM. During the last decade, the rapidly growing research field of metabolomics has introduced new insights into the pathology of diabetes as well as
Search for other papers by Robin Haring in
Google Scholar
PubMed
-onset hypogonadism, remains a controversial concept with several outstanding questions ( Box 1 ). Metabolomics for the improved diagnosis, therapy and monitoring of ADS The principle techniques of metabolomics Against the background of the various uncertainties
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Maik Pietzner in
Google Scholar
PubMed
Search for other papers by Tim Kacprowski in
Google Scholar
PubMed
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Nele Friedrich in
Google Scholar
PubMed
. Metabolomics THs affect diverse aspects of human metabolism and metabolomics techniques are ideally suited to map and connect these effects in a hypothesis-free manner. Figure 2 provides a sketch summarizing important findings from metabolomics studies with
VCA Colonial Animal Hospital, Ithaca, New York, USA
Search for other papers by Michael Merkhassine in
Google Scholar
PubMed
Weill Cornell College of Medicine, New York, New York, USA
Search for other papers by Reilly W Coch in
Google Scholar
PubMed
Search for other papers by Carol E Frederick in
Google Scholar
PubMed
Search for other papers by Lucinda L Bennett in
Google Scholar
PubMed
Fate Therapeutics, San Diego, California, USA
Search for other papers by Seth A Peng in
Google Scholar
PubMed
Search for other papers by Benjamin Morse in
Google Scholar
PubMed
Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA
Search for other papers by Bethany P Cummings in
Google Scholar
PubMed
Search for other papers by John P Loftus in
Google Scholar
PubMed
hyperglucagonemia on glucose and AA metabolism is lacking. We aimed to address two critical gaps in glucagon biology with broad applications for canine health and foundations for translational research. First was the lack of metabolomic data in dogs as a
Search for other papers by Lucy M Hinder in
Google Scholar
PubMed
Search for other papers by Anuradha Vivekanandan-Giri in
Google Scholar
PubMed
Search for other papers by Lisa L McLean in
Google Scholar
PubMed
Search for other papers by Subramaniam Pennathur in
Google Scholar
PubMed
Search for other papers by Eva L Feldman in
Google Scholar
PubMed
et al . 2007 ), retina ( Ola et al . 2006 ), and lens ( Obrosova & Stevens 1999 ). Recent metabolomic studies in models of type 1 diabetes reported downregulation of key TCA cycle and mitochondrial proteins ( Akude et al . 2011 ) and enzyme
Early Life Research Unit, INRA and University of Nantes, School of Veterinary Medicine and Science, Institute of Health Sciences, Oniris, Department of Animal Science, Academic Division of Child Health, Obstetrics and Gynaecology, School of Medicine, Queen's Medical Centre, The University of Nottingham, Nottingham NG7 2UH, UK
Search for other papers by Neele S Dellschaft in
Google Scholar
PubMed
Search for other papers by Marie-Cecile Alexandre-Gouabau in
Google Scholar
PubMed
Search for other papers by David S Gardner in
Google Scholar
PubMed
Search for other papers by Jean-Philippe Antignac in
Google Scholar
PubMed
Search for other papers by Duane H Keisler in
Google Scholar
PubMed
Search for other papers by Helen Budge in
Google Scholar
PubMed
Search for other papers by Michael E Symonds in
Google Scholar
PubMed
Early Life Research Unit, INRA and University of Nantes, School of Veterinary Medicine and Science, Institute of Health Sciences, Oniris, Department of Animal Science, Academic Division of Child Health, Obstetrics and Gynaecology, School of Medicine, Queen's Medical Centre, The University of Nottingham, Nottingham NG7 2UH, UK
Search for other papers by Sylvain P Sebert in
Google Scholar
PubMed
Washington, NY, USA) to remove high-molecular-weight species, proteins in particular (over 10 kDa). Metabolomic LC–HRMS profiles were acquired from 15 μl of each filtered serum sample using an Agilent 1200 HPLC system equipped with a 150×2.1 mm Uptisphere HDO
Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands
Search for other papers by Heleen I Jansen in
Google Scholar
PubMed
Search for other papers by Eveline Bruinstroop in
Google Scholar
PubMed
Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Search for other papers by Anita Boelen in
Google Scholar
PubMed
using omics are used to examine not only one marker but determine multiple markers in order to unravel a panel of markers representing (tissue) TH status. Metabolomic profiling is a powerful tool for measuring the activity of metabolic tissues ( Newgard
Search for other papers by Henri Wallaschofski in
Google Scholar
PubMed
be achieved by the approach of metabolomics. Metabolomics is a technique that provides a comprehensive assessment of small molecular mass organic compounds that are substrates or products of metabolic pathways as an individual fingerprint of
Search for other papers by Georg Homuth in
Google Scholar
PubMed
Search for other papers by Alexander Teumer in
Google Scholar
PubMed
Search for other papers by Uwe Völker in
Google Scholar
PubMed
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Toward a combination of genomics and metabolomics: a chronology Technological prerequisites and general significance Key prerequisites for the feasibility of genome-wide association studies (GWAS) were the availability of a first human genome
Faculty of Chemical Technology, University of Chemistry and Technology Prague, Prague, Czech Republic
Search for other papers by Martina Bugáňová in
Google Scholar
PubMed
Search for other papers by Helena Pelantová in
Google Scholar
PubMed
Search for other papers by Martina Holubová in
Google Scholar
PubMed
Search for other papers by Blanka Šedivá in
Google Scholar
PubMed
Search for other papers by Lenka Maletínská in
Google Scholar
PubMed
Search for other papers by Blanka Železná in
Google Scholar
PubMed
Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
Search for other papers by Jaroslav Kuneš in
Google Scholar
PubMed
Faculty of Chemical Technology, University of Chemistry and Technology Prague, Prague, Czech Republic
Search for other papers by Petr Kačer in
Google Scholar
PubMed
Search for other papers by Marek Kuzma in
Google Scholar
PubMed
Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
Search for other papers by Martin Haluzík in
Google Scholar
PubMed
therapies. NMR-based metabolomics in biofluids (e.g. urine or blood plasma) has become a strong tool for monitoring of different physiological and pathological processes as well as the response to the various therapeutic interventions ( Nicholson et al